CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sep. 5, 2013--
Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), today announced that David
Schenkein, M.D., chief executive officer, will present at the Morgan
Stanley Global Healthcare conference on Wednesday, September 11, 2013 at
11:45 a.m. ET in New York City.
A live webcast of Agios’ presentation can be accessed by visiting the
investors section of the company’s website at investor.agios.com.
A replay of the webcast will be archived on the Agios website for two
weeks following the presentation.
About Agios Pharmaceuticals, Inc.
Agios Pharmaceuticals is focused on discovering and developing novel
drugs to treat cancer and rare metabolic genetic diseases (known as
inborn errors of metabolism or IEMs) through scientific leadership in
the field of cellular metabolism. In addition to an active research and
discovery pipeline across both therapeutic areas, Agios has multiple
first-in-class lead product candidates in cancer metabolism and IEMs
advancing toward the clinic. All Agios programs focus on genetically
identified patient populations leveraging our knowledge of metabolism,
biology and genomics. For more information, please visit our website at www.agios.com.
Source: Agios Pharmaceuticals, Inc.
Agios Pharmaceuticals, Inc.
Media Contact:
Dan Budwick,
973-271-6085
dan@purecommunicationsinc.com
or
Investor
Contact:
Glenn Goddard
investors@agios.com
